2602 PUBLICATIONS
ANNÉE
JOURNAL
PREMIER AUTEUR
TITRE
ANNÉE2019
JOURNALBulletin du cancer
PREMIER AUTEURHelleux A
TITRE[Epigenetic alterations in kidney cancers].
ANNÉE2019
JOURNALCancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
PREMIER AUTEURNguyen MN
TITRE[Reirradiation of brain metastasis: Review of the last five years].
ANNÉE2019
JOURNALEuropean journal of cancer (Oxford, England : 1990)
PREMIER AUTEURPivot X
TITREThree-year follow-up from a phase 3 study of SB3 (a trastuzumab biosimilar) versus reference trastuzumab in the neoadjuvant setting for human epidermal growth factor receptor 2-positive breast cancer.
ANNÉE2019
JOURNALWorld journal of gastrointestinal oncology
PREMIER AUTEURBasso V
TITRESafety and efficacy of a docetaxel-5FU-oxaliplatin regimen with or without trastuzumab in neoadjuvant treatment of localized gastric or gastroesophageal junction cancer: A retrospective study.
ANNÉE2019
JOURNALOncogene
PREMIER AUTEURBuffière A
TITRET-cell acute lymphoblastic leukemia displays autocrine production of Interleukin-7.
ANNÉE2019
JOURNALEuropean journal of obstetrics, gynecology, and reproductive biology
PREMIER AUTEURLagrange A
TITREVisceral osteopathic manipulative treatment reduces patient reported digestive toxicities induced by adjuvant chemotherapy in breast cancer: A randomized controlled clinical study.
ANNÉE2019
JOURNALInternational journal of cancer
PREMIER AUTEURGalaine J
TITRECD4 T cells target colorectal cancer antigens upregulated by oxaliplatin.
ANNÉE2019
JOURNALAnnals of surgery
PREMIER AUTEURMariette C
TITREHealth-related Quality of Life Following Hybrid Minimally Invasive Versus Open Esophagectomy for Patients With Esophageal Cancer, Analysis of a Multicenter, Open-label, Randomized Phase III Controlled Trial: The MIRO Trial.
ANNÉE2019
JOURNALEuropean journal of nuclear medicine and molecular imaging
PREMIER AUTEURPayan N
TITREBiological correlates of tumor perfusion and its heterogeneity in newly diagnosed breast cancer using dynamic first-pass F-FDG PET/CT.
ANNÉE2019
JOURNALSeminars in cancer biology
PREMIER AUTEURKaramanou K
TITREEpithelial-to-Mesenchymal Transition and invadopodia markers in breast cancer: Lumican a key regulator.

Retrouvez aussi

Personnes
Equipes
Plateformes
Unités de recherche, établissements
Projets de recherche
Publications scientifiques